PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

128 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Weber, E.* et al.: Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local anti-viral response. J. Virol. 88, 12202-12212 (2014)
42.
Benhenda, S.* et al.: Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of Hepatitis B Virus transcription. J. Virol. 87, 4360-4371 (2013)
43.
Lankisch, P.* ; Adler, H. & Borkhardt, A.*: Testing for herpesvirus infection is essential in children with chromosomal-instability syndromes. J. Virol. 87, 3616-3617 (2013)
44.
Siegler, V.D. & Bruß, V.: Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis. J. Virol. 87, 1491-1496 (2013)
45.
Vidy, A.* et al.: Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo. J. Virol. 87, 4596-4608 (2013)
46.
Kalla, M. ; Göbel, C. & Hammerschmidt, W.: The lytic phase of Epstein-Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. J. Virol. 86, 447-458 (2012)
47.
Koppensteiner, H.* ; Banning, C.* ; Schneider, C.* ; Hohenberg, H.* & Schindler, M.: Macrophage internal HIV-1 is protected from neutralizing antibodies. J. Virol. 86, 2826-2836 (2012)
48.
Schneider, M. et al.: Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J. Virol. 86, 10112-10122 (2012)
49.
Pascutti, M.F.* et al.: Interplay between modified vaccinia virus Ankara and dendritic cells: Phenotypic and functional maturation of bystander dendritic cells. J. Virol. 85, 5532-5545 (2011)
50.
Ruiss, R. et al.: A virus-like particle-based Epstein-Barr virus vaccine. J. Virol. 85, 13105-13113 (2011)
51.
Arzberger, S. ; Hösel, M.* & Protzer, U.: Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus. J. Virol. 84, 11994-12001 (2010)
52.
Busse, C.* et al.: Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding. J. Virol. 84, 1139-1147 (2010)
53.
Deutsch, M.J. ; Ott, E. ; Papior, P. & Schepers, A.: The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus. J. Virol. 84, 2533-2546 (2010)
54.
Heinzelmann, K. et al.: Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling. J. Virol. 84, 12255-12264 (2010)
55.
Iskra, S. ; Kalla, M. ; Delecluse, H.J.* ; Hammerschmidt, W. & Moosmann, A.: Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus. J. Virol. 84, 3612-3623 (2010)
56.
Zhu, J.Y.* et al.: Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68. J. Virol. 84, 10266-10275 (2010)
57.
Ejegod, D.* et al.: Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element. J. Virol. 83, 336-346 (2009)
58.
Faumont, N.* et al.: C-Myc and Rel/NF-κB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J. Virol. 83, 5014-5027 (2009)
59.
Flach, B. ; Steer, B. ; Thakur, N.N. ; Haas, J.* & Adler, H.: The M10 locus of murine gammaherpesvirus 68 contributes to both the lytic and the latent phases of infection. J. Virol. 83, 8163-8172 (2009)
60.
Jochmann, R.* et al.: O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. J. Virol. 83, 3704-3718 (2009)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮